Paolo Emanuele Levi Setti
Rozzano, MI, 20089, Italy
NCT Number: NCT03611907
In the early stages of assisted reproductive technologies (ART), oocyte retrieval was performed via laparoscopy, a cumbersome and expensive process requiring general anesthesia. Today, transvaginal oocyte retrieval for ART is a routine procedure performed under ultrasound guidance. Double-lumen retrieval needles, which are capable of flushing ovarian follicles, were developed to overcome the possibility of oocyte retention within the ovarian follicles and retrieval collection system. Single lumen needles have been introduced and are routinely used by most groups due to their supposed ability to retrieve the same number of oocytes in a shorter operation time.
Looking for future studies?
Notify Me18 year–42 year
Female
Interventional
Not applicable
Rozzano, MI, 20089, Italy
After a long period in which Humanitas department used double lumen needles for oocytes retrieval in the last four years the choice of the needle is an operator choice, usually influenced by the number of follicles present at human Chorionic Gonadotropin (hCG) trigger.
This prospective randomized controlled clinical trial is designed to highlight differences between Double Lumen Aspiration Needle and Single Lumen Needle commonly used in Humanitas' clinical practice primarly in terms of number of retrived oocytes per procedure (A). Secondary outcomes are the number of punctured follicles (B), the retrieval rate (%) (A/B), the number of follicles at the last ultrasound performed prior to the ovulation trigger (C), the number of retrieved oocytes / number of follicles at trigger-day (A/C), retrieval procedure time (D), single oocyte retrieval time (D/A), the number of mature oocytes (and MII) and complications rate. Number of transferred embryos, number of frozen embryos and oocytes, clinical pregnancy rate per retrieval and per transfer (considering the number of pregnancies diagnosed by US visualization of one or more gestational sacs or definitive clinical signs of pregnancy per 100 cycles) and total number of clinical pregnancies with fetal heart beat (confirmed by visualization of one or more embryos with heartbeat at early dating ultrasound), are also evaluated. Standard protocols will be used for controlled ovarian hyper stimulation. Trans vaginal ultrasound-guided oocyte retrieval will be performed 36 hours ± 2 after hCG injection with the patient under deep sedation.
One hundred patients per each needle will be enrolled in this trial.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In this intervention a 17-Gauge needle is used to aspirate the follicles
In this intervention a 17-Gauge needle is used to aspirate follicle, and consequently a 1 mL flush is injected and aspirated twice for each punctured follicle
Time frame: through study completion, 9 months
Comparison of the number of retrieved oocytes per procedure among the two arms
Time frame: through study completion, 9 months
comparison between the recovery time for single oocyte in days among the two arms
Time frame: through study completion, 9 months
A comparison between the percentage of MII oocytes retrieved among the two arms
Time frame: through study completion, 9 months
Comparison between the oocyte retrieval percentage per aspirated follicles among the two arms
Time frame: through study completion, 9 months
Comparison of the number of punctured follicles among the two arms
Time frame: through study completion, 9 months
Comparison of the number of follicles at the trigger day among the two arms
Time frame: through study completion, 9 months
Comparison of the number of retrieved oocytes/ number of follicles at the trigger day among the two arms
Time frame: through study completion, 9 months
Comparison of the time of the single procedure among the two arms
Time frame: through study completion, 9 months
Comparison of the complication rate among the two arms
Istituto Clinico Humanitas
Other
Prospective Randomized Controlled Trial Comparing Different Needles for Oocyte's Retrieval.
Acronym: NEEDLE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04395755
ART, COVID-19
Genoa, Italy
View Trial DetailsNCT06139757
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Chicago, Illinois, United States
View Trial DetailsNCT03712982
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Waltham, Massachusetts, United States
View Trial DetailsNCT05698550
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Jinan, Shandong, China
View Trial Details